February 19, 2025

Lithium Blood Levels Predict Thyroid, Kidney Risks

Lithium therapy in bipolar disorder patients is linked to increased risks of hypothyroidism and chronic kidney disease, with specific serum level thresholds informing optimal treatment strategies, according to a large cohort study.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 10, 2025

Guideline-Based Mental Health Treatment Gaps Identified

Researchers found significant gaps in mental health and substance use disorder treatment.

Conexiant

February 07, 2025

Long-Term Rise in Cannabis-Associated Schizophrenia Cases, Predating Legalization

Researchers found that the proportion of schizophrenia cases linked to cannabis use disorder nearly tripled post-legalization, with the highest impact among young males.

Conexiant

February 06, 2025

Meds that May Increase Dementia Risk

Antimicrobials, anti-inflammatories, and vaccines were associated with reduced dementia risk, while antipsychotics, antidepressants, and diabetes medications were frequently associated with increased dementia risk.

Conexiant

January 31, 2025

Higher Antipsychotic Doses Linked to TD Risk

Doses greater than 75 mg/d of antipsychotics significantly increased the risk of tardive dyskinesia, with odds ratios up to 3.5, according to a claims database study of corporate healthcare beneficiaries.

Conexiant

January 28, 2025

Trial Data Behind FDA Psychiatric Approvals

Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.

Conexiant

January 24, 2025

Higher Cannabis Use Disorder Rates Linked to Medical Cannabis

Medical cannabis tied to increased cannabis use disorder and frequency in young U.S. adults, study finds.

Conexiant

May 28, 2024

New Help for Dealing With Aggression in People With Dementia

New tool offers free training in the DICE approach to help manage neuropsychiatric symptoms of dementia, including aggression, wandering, and resistance to care.

KFF Health News